Tenax Therapeutics Inc.

NASDAQ: TENX · Real-Time Price · USD
5.90
-0.05 (-0.84%)
At close: Aug 15, 2025, 3:59 PM
6.09
3.22%
After-hours: Aug 15, 2025, 05:30 PM EDT

Tenax Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a 2K n/a n/a n/a 5.79K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a 1K n/a 1K n/a 4.67K 1K 1K 895.00 29.2K 28.51K 28.01K 27.61K 26.83K 26.27K 25.66K 30.22K
Gross Profit
n/a n/a 1K n/a -1K n/a 1.12K -1K -1K -895 -29.2K -28.51K -28.01K -27.61K -26.83K -26.27K -25.66K -30.22K
Operating Income
-11.79M -11.34M -31.69M 4.62M -3.67M -3.91M -13.13M 2.12M -1.24M -1.54M -19.55M 2.92M -2.86M 2.72M -3.21M -3.8M -1.96M -23.75M
Interest Income
954K 930K 1.03M 664.72K 104.88K n/a n/a 150.74K 139.86K n/a n/a n/a 63.00 n/a n/a n/a n/a n/a
Pretax Income
-10.85M -10.41M -6.27M -3.96M -3.58M -3.8M -3.23M -1.97M -1.11M -1.41M -2.55M -2.92M -2.86M -2.72M -3.21M -3.8M -1.72M -23.75M
Net Income
-10.85M -10.41M -6.27M -3.96M -3.58M -3.8M -3.23M -1.97M -1.11M -1.41M -2.55M -2.92M -2.86M -2.72M -3.21M -3.8M -1.72M -23.75M
Selling & General & Admin
5.67M 5.66M 2.7M 1.51M 1.34M 1.23M 1.64M 1.05M 1.04M 1.27M 1.42M 1.38M 1.34M 1.54M 2.3M 2.64M 1.27M 1.37M
Research & Development
6.12M 5.68M 4.59M 3.11M 2.33M 2.68M 1.7M 1.07M 197.9K 265.74K 1.13M 1.54M 1.52M 1.18M 915.6K 1.16M 693.22K 22.38M
Other Expenses
n/a n/a 24.4M n/a n/a n/a 9.79M -4.23M -0.00 n/a 5.82K -5.83M 0.00 -5.44M n/a n/a n/a n/a
Operating Expenses
11.79M 11.34M 31.69M 4.62M 3.67M 3.91M 13.13M -2.12M 1.24M 1.54M 2.55M -2.92M 2.86M -2.72M 3.21M 3.8M 1.96M 23.75M
Interest Expense
n/a n/a -464 6.31K 9.19K 7.96K 2.15K 5.34K 9.13K 7.35K 4.07K 372.00 1.48K 2.59K n/a n/a 336.00 613.00
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
11.79M 11.34M 31.69M -4.62M 3.67M 3.91M 3.34M -2.12M 1.24M 1.54M 2.55M -2.92M 2.86M -2.72M 3.21M 3.8M 1.96M 23.75M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -4.07K n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
39.57M 36.58M 15.27M 21.16M 1.96M 1.22M 248.45K 298.28K 276.45K 116.26K 1.47M 16.46K 15.75K 15.75K 20.58M 15.75K 10.76K 14.52M
Shares Outstanding (Diluted)
39.57M 36.58M 15.27M 21.16M 1.96M 1.22M 248.45K 298.28K 276.45K 116.26K 1.47M 16.46K 15.75K 15.75K 20.58M 15.75K 10.76K 14.52M
EPS (Basic)
-0.27 -0.28 -0.18 -0.19 -1.83 -3.12 -10.81 -6.61 -4 -12.1 -101.79 -177.6 -181.6 -172.8 -214.04 -241.18 -159.56 -2.62K
EPS (Diluted)
-0.27 -0.28 -0.18 -0.19 -1.83 -3.12 -10.81 -6.61 -4 -12.1 -99.44 -177.6 -181.6 -172.8 -203.38 -241.18 -159.56 -2.62K
EBITDA
-10.85M -10.41M -6.27M -3.95M -3.57M -3.79M -3.22M -1.97M -1.1M -1.4M -2.52M -2.89M -2.83M -2.69M -3.18M -3.77M -1.69M -23.72M
EBIT
-10.85M -10.41M -6.27M -3.95M -3.57M -3.79M -3.22M -1.97M -1.1M -1.4M -2.55M -2.92M -2.86M -2.72M -3.21M -3.8M -1.72M -23.75M
Depreciation & Amortization
n/a n/a n/a -1.89K 1K 1.89K 4.71K 969.00 1K 895.00 29.2K 28.51K 28.01K 27.61K 26.83K 26.27K 25.66K 30.22K